China Pharma Holdings (CPHI) Exchange Rate Effect (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Exchange Rate Effect came in at -$42021.0 in Q1 2026, down 682.37% YoY from $7215.5 in Q1 2025, and down 1189.76% on a QoQ basis from $3856.0 in Q4 2025.
China Pharma Holdings (CPHI) Exchange Rate Effect (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of Exchange Rate Effect data on file, last reported at -$42021.0 in Q1 2026.
- Quarterly Exchange Rate Effect fell 682.37% year-over-year to -$42021.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$35400.0 (up 44.78% YoY) and the FY2025 annual result came in at $1250.0, up 101.91% from the prior year.
- Exchange Rate Effect retreated to -$42021.0 in Q1 2026, from $3856.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $50439.0 in Q4 2023 to a low of -$153626.0 in Q3 2022.
- A 5-year average of -$18930.3 and a median of -$5371.0 in 2025 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 1283.72% in 2022, down 3654.3% in 2022.
- Tracing CPHI's Exchange Rate Effect over 5 years: stood at $3874.0 in 2022, then jumped by 1201.99% to $50439.0 in 2023, then plunged by 225.7% to -$63400.0 in 2024, then soared by 106.08% to $3856.0 in 2025, then slumped by 1189.76% to -$42021.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$42021.0 (Q1 2026), $3856.0 (Q4 2025), and $42392.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -5.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -7.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 39.87 Mn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -3.30 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 9.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | China Pharma Holdings | 42.35 Mn | 42.04 Mn | 83,566.00 | 49,110.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42,021.00 |
| Mar 31, 2026 | -42,021.00 |
| Dec 31, 2025 | 3,856.00 |
| Dec 31, 2025 | 3,856.00 |
| Sep 30, 2025 | 42,392.00 |
| Sep 30, 2025 | 42,392.00 |
| Jun 30, 2025 | -39,627.00 |
| Jun 30, 2025 | -39,627.00 |
| Mar 31, 2025 | -5,371.00 |
| Mar 31, 2025 | -5,371.00 |
| Dec 31, 2024 | -63,400.00 |
| Dec 31, 2024 | -63,400.00 |
| Sep 30, 2024 | 10,243.00 |
| Sep 30, 2024 | 10,243.00 |
| Jun 30, 2024 | -5,584.00 |
| Jun 30, 2024 | -5,584.00 |
| Mar 31, 2024 | -6,655.00 |
| Mar 31, 2024 | -6,655.00 |
| Dec 31, 2023 | 50,439.00 |
| Dec 31, 2023 | 50,439.00 |